Norris Medicines Ltd — Quarterly Results & Earnings

₹13.35

-1.70%

Profit Growth YoY-100.00%Latest quarter

Sales Growth YoY57.48%Latest quarter

Sales CAGR 5Y-5.78%5 year compound

Profit CAGR 5Y9.35%5 year compound

📋

Quarterly Performance

YoY Profit Growth-100.00%

🔴 Significant decline

YoY Sales Growth+57.48%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

-3.20%

EPS Growth 5Y

9.35%

Interest Coverage

Higher = safer debt servicing

-2.02

ROE

N/A

ROCE

-10.13%

💡

Growth Analysis

Norris Medicines Ltd reported YoY profit growth of -100.00% and revenue growth of 57.48% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -5.78% and profits at 9.35% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Norris Medicines Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Trading & Distributors Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.